Table 3. Outcomes after the final assessment

	Biliopancreatic tunneling (n=5)	Choledochojejunostomy (n=3)	p-value
Mean length of follow-up (months)	5 (4–16)	15 (15–16)	p=0.21)
Izbicki score	9 (0–20)	18 (0–20)	p=0.61)
Effective pain relief (%)	100	100
Complete pain relief (%)	80	33	p=0.52)
SF-12 PCS	88 (58–100)	71 (54–100)	p=0.61)
SF-12 MCS	80 (56–97)	74 (70–100)	p=11)
Endocrine insufficiency (%)	20	33	p=12)
Exocrine insufficiency (%)	40	33	p=12)
Nausea (%)	0	0
Weight loss (%)	20	0	p=12)
Anorexia (%)	0	0
Recurrent biliary obstruction (%)	20	0	p=12)

Wilcoxon rank-sum test, with the Shapiro-Wilk test, showed an abnormal distribution of variables.
Fisher exact test.
PCS, physical component summary; MCS, mental component summary.